SPHS - Sophiris Bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
12.41M
Enterprise Value 3
11.7M
Trailing P/E
360.00
Forward P/E 1
-1.24
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-1.16

Trading Information

Stock Price History

Beta (3Y Monthly) 1.20
52-Week Change 3-82.86%
S&P500 52-Week Change 318.39%
52 Week High 32.1900
52 Week Low 30.3400
50-Day Moving Average 30.4709
200-Day Moving Average 30.7355

Share Statistics

Avg Vol (3 month) 3194.21k
Avg Vol (10 day) 3147k
Shares Outstanding 534.47M
Float 32.62M
% Held by Insiders 10.85%
% Held by Institutions 17.94%
Shares Short (Nov 15, 2019) 41.4M
Short Ratio (Nov 15, 2019) 45.92
Short % of Float (Nov 15, 2019) 44.66%
Short % of Shares Outstanding (Nov 15, 2019) 44.07%
Shares Short (prior month Oct 15, 2019) 41.38M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 252/1
Last Split Date 3Aug 15, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-56.39%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -10.07M
Net Income Avi to Common (ttm)37k
Diluted EPS (ttm)0.0010
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.3M
Total Cash Per Share (mrq)0.18
Total Debt (mrq)5.84M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.79
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-10.54M
Levered Free Cash Flow (ttm)-6.83M